本公司透過解決失智症與年齡相關記憶衰退問題來創造營收。

這項使命主要是透過販售 Memfocus™ 來實現，該產品含有 Psychlomin™（6-MSITC）——一種對記憶力有顯著影響的小分子。

我們甚至將其註冊為商標，稱之為「記憶分子™（The Memory Molecule™）」，可見其重要性。
 
有多顯著呢？在針對年長族群進行的臨床試驗中，6-MSITC 對情節記憶的提升幅度達 18%，成效顯著。
 
目前 Memfocus™ 已開始透過官方網站 Memfocus.com 以及線上通路 Amazon 銷售。
 
接下來，公司也將推出一項結合產品與智慧財產的創新功能：記憶力 AI 評估網頁應用程式。

用戶透過此 AI 系統進行記憶力評估後，會獲得一套個人化的健康改善方案（如運動、遊戲、營養等），並搭配植物性膳食補充品 Memfocus。

完成該方案後，用戶再次接受記憶力評估，AI 會根據新結果提供下一階段的個人化建議，如此反覆循環，持續優化記憶健康。
 
在這個評估與調整過程中，系統也會帶動營收，包括 訂閱制 或 單次銷售 的方式提供 Memfocus 與健康內容。

The Company is generating revenues by addressing dementia and age-related memory loss.

The Company does this through the sales of Memfocus™, which contains Psychlomin™ (6-MSITC), a significant memory impacting small molecule.

It is so significant that we trademarked it as “The Memory Molecule™”.
How significant? The results of a significant clinical trial of 6-MSITC in an elderly population showed an 18% increase in episodic memory.

Memfocus™ sales just started happening through Memfocus.com and the online retailer, Amazon.

A coming feature and the Company’s intellectual property (IP) of the product is an artificial intelligence (AI) webapp that provides a memory assessment.

Based upon the results of the memory assessment, the client is provided a unique regimen of wellness content (exercises, games, nutrition, etc.) and the plant-based Memfocus dietary supplement. After that regimen is completed, the client takes a new memory assessment.

With those results, the AI provides a new regimen, and this system repeats going into the future.

During the assessment, a revenue-generating subscription model or one-off sales of Memfocus and wellness content occurs.


Jason E. Barkeloo，文學碩士，創辦人兼執行長：創立五家新創公司，並成功將其中一家公司出售給上市公司。科學教育者、投資人、擁有專利發明者及演講者。

Jason E. Barkeloo, MA, Founder/CEO: Founded five startups with an exit to a publicly traded company. Science educator. Investor. Patented. Speaker.


Elizabeth Cottingham，醫學博士，聯合創辦人兼首席科學官：精神科醫師、研究員。擁有美國專利「二甲雙胍作為非典型抗精神病藥輔助療法」，並已將該專利授權給一家大型製藥公司。

Elizabeth Cottingham, MD, co-Founder: Chief Science Officer: Psychiatrist. Researcher. USA patented “metformin as adjunctive therapy to atypical antipsychotics” Licensed that patent to a large pharmaceutical company.


P.J. Hussey，聯合創辦人兼首席營運官。醫療服務與六標準差專家。房地產及股票投資人。

P.J. Hussey, co-Founder, Chief Operating Officer. Healthcare Delivery and Six Sigma Expert. Real-estate and equities investor.


Kelly Land，聯合創辦人：專業投資人。銷售與行銷顧問。全球軟體市場專家。

Kelly Land, co-Founder: Professional investor. Sales and marketing advisor. Global software market expert.